An international non-profit organisation, The Programme for Appropriate Technology in Health (PATH) Ghana, will begin a three year project called Oxytocin Initiative(OI) in the country to complement government’s efforts to reduce maternal mortality. Oxytocin is a life saving drug recommended by the World Health Organisation (WHO) for the prevention and treatment of postpartum haemorrhage. PATH has offices in 70 countries to create sustainable, culturally relevant solutions and breaks long standing cycles of poor health of the communities. The vision of the organisation is to improve the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviours.
The project has been funded by Bill and Melinda Gates foundation and aims to achieve the millennium development goal by improving maternal health and reduce maternal mortality in Ghana. The community based health workers will be using the uniject injection device through which oxytocin will be administered. The initiative was jointly developed by PATH, Johns Hopkins Bloomberg School of Public Heath, the Family Health Division and the Kintampo Health Centre under the Research Development of the Ghana Health Service. The rich experience of the organisation in developing solutions would provide government with a strategic advantage to test some of the innovations.